Dr. Mark D. Anderson, MD

Dr. Anderson practices at University of Mississippi Medical Center in Jackson, Mississippi, part of Mississippi Institutions of Higher Learning.

Dr. Anderson's NPI, 1922202415, was assigned on June 11, 2007. Dr. Anderson graduated from University of Alabama School of Medicine in 2007. Dr. Anderson holds Mississippi license 22703.

Dr. Anderson's primary practice is University of Mississippi Medical Center, at 2500 N State St, Jackson, MS 39216 in Hinds County. The practice phone is (601) 984-4100.

Dr. Anderson's primary practice is University of Mississippi Medical Center in Jackson, Mississippi, part of Mississippi Institutions of Higher Learning. Dr. Anderson is also affiliated with Baptist Anderson Regional Medical Center. The medical group on file is University of Mississippi Medical Center. Dmand AI also links Dr. Anderson to 1 more hospital and 1 behavioral health center, each named with a free account. Dr. Anderson's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Anderson practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Anderson's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Anderson is licensed in Mississippi.

CMS data shows 305 Medicare services from Dr. Anderson across 6 procedure codes in 2024, for 218 Medicare patients. Medicare paid $22,721 for them.

CMS counts 218 Medicare patients who saw Dr. Anderson in 2024. The largest group is under 65, with 83 patients. 74% of them have high blood pressure, and 58% have high cholesterol. 35% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Anderson's median patient age at 53, with 65% women.

In 2024, Dr. Anderson wrote 2,594 Medicare Part D claims for 258 patients. 89% of them were for generic drugs. CMS names the drug for 2,232 of them, across 61 drugs with 11 or more claims each, at $444,301 in total drug cost. In 2023, CMS named 2,097 claims across 64 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Anderson for performance year 2024, reported as part of a group. Dr. Anderson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Anderson as offering telehealth.

Dmand AI links 17 papers to Dr. Anderson, published from 2012 to 2023. 2013 was the busiest year, with 4. The most frequent topics are Brain Neoplasms, Isocitrate Dehydrogenase and Neoplasm Grading. Dr. Anderson's most frequent co-authors are Mark Raymond Gilbert, MD, Sajeel A. Chowdhary, MD and George Ansstas, MD.

Dmand AI links Dr. Anderson to 5 clinical trials, 3 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Glioblastoma, Astrocytoma and Brain Neoplasms.

CMS Open Payments shows 523 general payments to Dr. Anderson from 86 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Janssen Pharmaceuticals, Inc paid the most, $830.

Dr. Anderson graduated from University of Alabama School of Medicine in 2007.